
Founder Mode: Jen Herbach, Founder & CEO, Adventris Pharmaceuticals
The Social Radars
00:00
Consequences of Refusing Investor Direction
Jen explains the fallout—losing that investor in a funding round—but gaining respect from other investors for standing by scientific decisions.
Transcript
Play full episode